13 Clinical Trials Found
Drug: JAB-21822单药
Indication: PDAC
Region: 中国
Drug: JAB-21822单药
Indication: PDAC, CRC, Other advanced solid tumors
Region: 中国
Drug: JAB-21822联合JAB-3312
Indication: NSCLC, PDAC, CRC, Other advanced solid tumors
Region: 中国
Drug: JAB-21822联合西妥昔单抗
Indication: Small bowel cancer, CRC, Appendiceal cancer
Region: 中国
Drug: JAB-3312联合奥希替尼
Indication: NSCLC
Region: 中国
Drug: JAB-3312联合奥希替尼
Indication: NSCLC
Region: 中国
Drug: JAB-3312联合帕博利珠单抗
Indication: ESCC
Region: 中国
Drug: JAB-3312联合帕博利珠单抗
Indication: ESCC
Region: 中国
Drug: JAB-8263单药
Indication: AML, PMF
Region: 中国
Drug: JAB-8263单药
Indication: BRD-NUT, Breast cancer, Prostate cancer, Ovarian cancer, Other advanced solid tumors
Region: 中国, 美国
Drug: JAB-BX102单药
Indication: Thyroid cancer, Sarcoma, ACC, Other advanced solid tumors
Region: 中国, 美国

Platform & Pipeline

Partnership